These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8603522)

  • 21. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.
    Jourdan M; Veyrune JL; De Vos J; Redal N; Couderc G; Klein B
    Oncogene; 2003 May; 22(19):2950-9. PubMed ID: 12771946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA), and GP130 antagonist (GP130A) using various parameters in an in vitro model.
    Kovacs E
    ScientificWorldJournal; 2006 Aug; 6():888-98. PubMed ID: 16892169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells.
    Schwabe M; Zhao J; Kung HF
    J Biol Chem; 1994 Mar; 269(10):7201-9. PubMed ID: 8125932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
    Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
    Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
    J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone and suramin inhibit cell proliferation and interleukin-6-mediated immunoglobulin secretion in human lymphoid and multiple myeloma cell lines.
    Shiao RT; Miglietta L; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1995 May; 17(5-6):485-94. PubMed ID: 7549842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6-receptor-mediated growth inhibition by all-trans retinoic acid but not by interferon-alpha in human myeloma cells.
    Pulkki K; Neva M; Koskela K; Ollikainen H; Remes K; Pelliniemi TT
    Ann N Y Acad Sci; 1995 Jul; 762():457-8. PubMed ID: 7668556
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of myeloma cell growth by all-trans retinoic acid is associated with upregulation of p21WAF1 and dephosphorylation of the retinoblastoma protein.
    Lavelle D; Chen YH; Hankewych M; Desimone J
    Leuk Lymphoma; 1999 Oct; 35(3-4):261-8. PubMed ID: 10706449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb.
    Autissier P; De Vos J; Liautard J; Tupitsyn N; Jacquet C; Chavdia N; Klein B; Brochier J; Gaillard JP
    Int Immunol; 1998 Dec; 10(12):1881-9. PubMed ID: 9885909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
    Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
    Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
    J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces apoptosis in multiple myeloma cells through the IL-6 signal transduction pathway and increases FOXO3a-Bim expression.
    Shen JK; Du HP; Ma Q; Yang M; Wang YG; Jin J
    Oncol Rep; 2013 Jul; 30(1):425-32. PubMed ID: 23624712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Alas S; Bonavida B
    Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.